Visual hallucinations at the onset of tolterodine treatment in a patient with a high-level spinal cord injury.
Malavaud
B
B
Department of Urology, Centre Hospitalo Universitaire Purpan, Toulouse, France.
Bagheri
H
H
Senard
J M
JM
Sarramon
J P
JP
D001559:Benzhydryl Compounds / Q000009:adverse effects*; D003408:Cresols / Q000009:adverse effects*; D005260:Female; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000009:adverse effects*; D010665:Phenylpropanolamine; D012021:Reflex, Abnormal / Q000502:physiology; D013119:Spinal Cord Injuries / Q000150:complications*; D000068737:Tolterodine Tartrate
D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate